01 3Copaxone
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : -2.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 4,237
2014 Revenue in Millions : 4,023
Growth (%) : -5%
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 4,223
2015 Revenue in Millions : 4,023
Growth (%) : 5
